← BioTransfer GEO Dataset Finder
GEO series

Understanding the mechanisms of resistance to BRAF inhibitors in colorectal cancer

GSE248414 Homo sapiens Expression profiling by high throughput sequencing 12 samples 2025/09/01 GPL29480
Summary
Mutations in proto-oncogene BRAF occur in about 10-15% of CRC patients and BRAFV600E is the most common. Most patients with BRAFV600E metastatic CRC show reduced survival compared to patients with wild-type BRAF. For patients who undergo BRAF-targeted therapy, resistance develops 4-6 months after treatment initiation and results in more aggressive disease. We established PT130 cells resistant to PLX8394, a novel BRAF inhibotor, and tested them in vitro and in vivo.
Download
NCBI GEO page ↗ {# Names what the click gives you. "Open in finder" meant nothing to a visitor who arrived from a search engine and has never seen the tool. #} Find more human RNA-seq datasets →
Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.